Lucid Diagnostics (LUCD) Non-Current Assets (2020 - 2026)
Lucid Diagnostics (LUCD) posted Non-Current Assets of $2.7 million for Q1 2026, down 8.7% on a QoQ basis from $3.0 million in Q4 2025, and down 48.31% year-over-year from $5.3 million in Q1 2025.
Lucid Diagnostics (LUCD) Non-Current Assets (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- Quarterly Non-Current Assets fell 48.31% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (down 38.99% YoY) and the FY2025 annual result came in at $3.0 million, down 46.52% from the prior year.
- Non-Current Assets was $2.7 million for Q1 2026 at Lucid Diagnostics, down from $3.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $9.7 million in Q1 2022 and bottomed at $2.7 million in Q1 2026.
- A 5-year average of $6.0 million and a median of $5.8 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 977.15% — and 2026, when it tumbled 48.31%.
- Lucid Diagnostics' Non-Current Assets stood at $8.2 million in 2022, then tumbled by 36.26% to $5.2 million in 2023, then grew by 7.12% to $5.6 million in 2024, then slumped by 46.52% to $3.0 million in 2025, then dropped by 8.7% to $2.7 million in 2026.
- Business Quant data shows LUCD's Non-Current Assets at $2.7 million in Q1 2026, $3.0 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Lucid Diagnostics | 127.56 Mn | 99.68 Mn | -325,000.00 | 2.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 3.36 Mn |
| Jun 30, 2025 | 4.84 Mn |
| Mar 31, 2025 | 5.26 Mn |
| Dec 31, 2024 | 5.57 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 5.20 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 6.74 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 8.15 Mn |
| Sep 30, 2022 | 8.53 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 9.73 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 791,812.00 |
| Dec 31, 2020 | 755,000.00 |